TB
Healthcare & Life Sciences

Tolerance Bio

United Statestolerancebio.com

Tolerance Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Seed, 2 tracked investors.

Activeseed
seed
Stage
2023
Founded
2
Investors

About Tolerance Bio

Based in the United States, Tolerance Bio is a startup founded in 2023. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.

Tolerance Bio develops therapies that restore, preserve, and manipulate thymus function to improve immune tolerance and extend healthspan.

Explore Tolerance Bio's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States